GSA Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,772
| Closed | -$367K | – | 1798 |
|
|
2025
Q1 | $367K | Buy |
+10,772
| New | +$367K | 0.03% | 1012 |
|
|
2022
Q2 | – | Sell |
-5,909
| Closed | -$371K | – | 1451 |
|
|
2022
Q1 | $371K | Buy |
+5,909
| New | +$371K | 0.05% | 736 |
|
|
2021
Q4 | – | Sell |
-2,647
| Closed | -$296K | – | 1459 |
|
|
2021
Q3 | $296K | Buy |
+2,647
| New | +$296K | 0.03% | 1028 |
|
|
2020
Q1 | – | Sell |
-19,666
| Closed | -$1.2M | – | 1135 |
|
|
2019
Q4 | $1.2M | Buy |
+19,666
| New | +$1.2M | 0.14% | 130 |
|
|
2018
Q2 | – | Sell |
-18,831
| Closed | -$861K | – | 1714 |
|
|
2018
Q1 | $861K | Sell |
18,831
-61,769
| -77% | -$2.82M | 0.05% | 759 |
|
|
2017
Q4 | $1.89M | Buy |
+80,600
| New | +$1.89M | 0.12% | 254 |
|